The Unstable Core: New Insights into Monoclonal Antibody Stability
A recent study in Molecular Pharmaceutics investigates the thermal stability of IgG4 monoclonal antibodies, a critical class of biopharmaceuticals. The research highlights the complex and sometimes ambiguous roles of formulation components like cosolutes, excipients, and salts in influencing both the conformational and colloidal stability of these therapeutic proteins. Understanding these interactions is vital for optimizing drug delivery systems and ensuring the efficacy and safety of monoclonal antibody treatments during storage and administration.
Study Significance: For pharmacologists and formulation scientists, this work directly addresses the practical challenges of therapeutic drug monitoring and shelf-life prediction. It underscores the need for a nuanced approach to formulation design, where standard excipients may have unpredictable effects on protein aggregation and degradation. This research advances the field of nanomedicine and biopharmaceutical development by providing a clearer framework for mitigating adverse drug reactions related to protein instability.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
